Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
0.00% | 3 | |
+6.68% | 113B | |
+10.90% | 106B | |
+0.87% | 22.27B | |
-12.85% | 22.22B | |
-5.71% | 19.43B | |
-37.85% | 17.87B | |
-6.75% | 17.24B | |
+7.39% | 14.29B | |
+34.66% | 12.52B |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- Transcript : Nabriva Therapeutics plc, Q3 2020 Earnings Call, Nov 05, 2020